FDA Adds New Gastrointestinal Side Effect Warning to Ozempic Label
FDA Adds New Gastrointestinal Side Effect Warning to Ozempic Label The U.S. Food and Drug Administration (FDA) has recently revised the labeling requirements for Ozempic, a medication commonly prescribed to manage type 2 diabetes. The updated label now includes a warning regarding potential gastrointestinal side effects that patients may experience while taking this drug. Ozempic … Read more
